- Akasa is a leading provider of generative AI solutions for the healthcare revenue cycle, recognized as one of America’s Best Startup Employers in 2026.
- In the past year, Akasa has launched its CDI Optimizer, a generative AI assistant aimed at transforming clinical documentation and mid-cycle performance, and has been certified as a Great Place to Work for the sixth consecutive year.
- The company has established strategic partnerships, including a collaboration with Cleveland Clinic to modernize the revenue cycle with AI tools, and has been recognized as the #1 Most Promising Healthcare RCM Startup of 2025 by Black Book Research.
- Ideal buyers include healthcare systems looking to enhance revenue cycle efficiency and accuracy, as Akasa addresses the growing demand for AI-driven solutions in healthcare documentation and financial operations.
Akasa's workforce is organized into 13 departments, with a total headcount of 118 employees. The largest departments include Information Technology with 19 employees, Engineering with 15, and Operations with 13. This distribution indicates a strong emphasis on technical and operational capabilities, which are critical for software development. The presence of smaller departments such as Marketing and Human Resources reflects a balanced approach to supporting the core functions of the organization.
The company's workforce is distributed across 22 locations, with a notable concentration in San Francisco, CA, housing 8 employees. Other significant locations include Chicago, IL, and New York, NY, each with 2 employees. The 'Other' category accounts for 58 employees, indicating a substantial remote or distributed workforce. This geographic distribution suggests a flexible operational model that leverages talent from various regions.
